62. 下列之臨床狀況，何者可與酒精性肝病相似？(1) Non-alcoholic fatty liver disease(2) Hereditary hemochromatosis(3) Amiodarone hepatotoxicity(4) Budd-Chiari syndrome(A) (1)＋(2)(B) (1)＋(3)(C) (1)＋(3)＋(4)(D) (1)＋(2)＋(3)(E) (1)＋(2)＋(3)＋(4)

62. 下列之臨床狀況，何者可與酒精性肝病相似？
(1) Non-alcoholic fatty liver disease
(2) Hereditary hemochromatosis
(3) Amiodarone hepatotoxicity
(4) Budd-Chiari syndrome
(A) (1)＋(2)
(B) (1)＋(3)
(C) (1)＋(3)＋(4)
(D) (1)＋(2)＋(3)

(E) (1)＋(2)＋(3)＋(4)

答案：登入後查看
統計： A(0), B(0), C(0), D(0), E(4) #3588518

詳解 (共 1 筆)

MoAI - 您的AI助手

B1 · 2025/09/30

#6814670

1. 題目解析本題旨在考察考生對於各...

(共 1040 字，隱藏中）

前往觀看

68. 依據 2023 AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma，下列何者敘述正確？(1) AASLD advises against the combination of systemic therapy withtransarterial therapies for BCLC Stage B HCC outside of a clinical trial setting(2) Patients with BCLC Stage B HCC should be treated with transarterialchemoembolization(3) AASLD advises radioembolization as an alternative therapy tochemoembolization in patients with BCLC Stage B HCC(4) Patients with Child-Turcotte-Pugh class C cirrhosis should be enrolled insurveillance programs(A) (3)＋(4)(B) (1)＋(2)(C) (3)(D) (1)＋(2)＋(3)(E) (1)＋(2)＋(3)＋(4)

62. 下列之臨床狀況，何者可與酒精性肝病相似？(1) Non-alcoholic fatty liver disease(2) Hereditary hemochromatosis(3) Amiodarone hepatotoxicity(4) Budd-Chiari syndrome(A) (1)＋(2)(B) (1)＋(3)(C) (1)＋(3)＋(4)(D) (1)＋(2)＋(3)(E) (1)＋(2)＋(3)＋(4)

詳解 (共 1 筆)

其他試題

62. 下列之臨床狀況，何者可與酒精性肝病相似？
(1) Non-alcoholic fatty liver disease
(2) Hereditary hemochromatosis
(3) Amiodarone hepatotoxicity
(4) Budd-Chiari syndrome
(A) (1)＋(2)
(B) (1)＋(3)
(C) (1)＋(3)＋(4)
(D) (1)＋(2)＋(3)

(E) (1)＋(2)＋(3)＋(4)